By Scott Gottlieb, M.D.
The tragic deaths of 55 Americans and sickening of more than 740, resulting from contaminated steroid injections that were shipped by a disreputable firm in Massachusetts, have focused public attention on a largely unfamiliar, but prominent part of our drug supply chain – the practice of pharmacycompounding. Observers are calling on Congress to give FDA more power over these firms.
New laws merit consideration, and yesterday I participated in a hearing before the House Energy and Commerce Committee, Subcommittee on Health, as legislators consider how to shore up supervision of the drugs produced by these pharmacies. My testimony is available online.
continue reading here
No comments:
Post a Comment